AI-generated summary
The authors compared routine occlusal splint and anti-inflammatory drug therapy with or without 940 nm low-level laser therapy in 40 patients with disc displacement with reduction of the temporomandibular joint. They report that VAS pain scores decreased in both groups, with significant differences at four and 12 weeks, and that maximal mouth opening was higher in the laser group at all time points. The authors conclude that short-term laser therapy added to conventional treatment may yield satisfactory outcomes.
- Participants
- 40
- Who or what was studied
- Adults with disc displacement with reduction of the temporomandibular joint (10 males, 30 females; age range 18 to 60 years)
- Wavelengths
- 940 nm
- Limits stated in the abstract
- The study involved only 40 patients split into two groups of 20, and the abstract does not describe randomization or blinding.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on ftrdergisi.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 940 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Low-level laser therapy, Visual analogue scale, Control group, Wavelength. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.